• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells.血管内皮生长因子B(VEGF-B)与血管内皮生长因子受体-1结合,并调节内皮细胞中的纤溶酶原激活物活性。
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11709-14. doi: 10.1073/pnas.95.20.11709.
2
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.鉴定血管内皮生长因子与KDR和FLT-1受体结合的决定因素。通过定点诱变产生受体选择性VEGF变体。
J Biol Chem. 1996 Mar 8;271(10):5638-46. doi: 10.1074/jbc.271.10.5638.
3
Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.血管内皮生长因子受体FLT-1胞外域配体结合位点及受体二聚化位点的定位
J Biol Chem. 1997 Apr 18;272(16):10382-8. doi: 10.1074/jbc.272.16.10382.
4
Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation.细胞外基质肌腱蛋白-X与血管内皮生长因子B联合作用可增强内皮细胞增殖。
Genes Cells. 2000 Nov;5(11):913-927. doi: 10.1046/j.1365-2443.2000.00376.x.
5
Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).血管内皮生长因子受体-1(Flt-1酪氨酸激酶)细胞外结构域的特征分析
Jpn J Cancer Res. 1997 Sep;88(9):867-76. doi: 10.1111/j.1349-7006.1997.tb00463.x.
6
Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.胎盘生长因子刺激丝裂原活化蛋白激酶和有丝分裂活性,但不刺激磷脂酶C-γ以及表达Flt 1的内皮细胞的迁移。
Oncogene. 1998 Jan 22;16(3):359-67. doi: 10.1038/sj.onc.1201545.
7
Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.肝细胞生长因子可增加人角质形成细胞中血管内皮生长因子和纤溶酶原激活物抑制剂-1的表达,以及人内皮细胞中血管内皮生长因子受体flk-1的表达。
Lab Invest. 1999 Apr;79(4):427-38.
8
Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.通过其7号外显子编码结构域结合VEGF165的肿瘤细胞上新型血管内皮生长因子(VEGF)受体的特性分析
J Biol Chem. 1996 Mar 8;271(10):5761-7. doi: 10.1074/jbc.271.10.5761.
9
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.一种新型血管内皮生长因子VEGF-C,是Flt4(血管内皮生长因子受体-3)和KDR(血管内皮生长因子受体-2)受体酪氨酸激酶的配体。
EMBO J. 1996 Jan 15;15(2):290-98.
10
Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.直接鉴定血管内皮生长因子受体Flt-1上介导磷脂酰肌醇3'-激酶结合的主要自磷酸化位点。
Biochem J. 2001 Sep 1;358(Pt 2):465-72. doi: 10.1042/0264-6021:3580465.

引用本文的文献

1
Obesity Alters the Vascular Morphology and VEGF-A Signaling in Adipose Tissue.肥胖改变脂肪组织中的血管形态和血管内皮生长因子A(VEGF-A)信号传导。
FASEB Bioadv. 2025 May 19;7(6):e70018. doi: 10.1096/fba.2025-00027. eCollection 2025 Jun.
2
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.健康与疾病中的血管内皮生长因子信号传导:从分子机制到治疗前景
Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0.
3
Unexpectedly High and Difficult-to-Explain Regenerative Capacity in an 82-Year-Old Patient with Insulin-Requiring Type 2 Diabetes and End-Stage Renal Disease.一名患有胰岛素依赖型2型糖尿病和终末期肾病的82岁患者出现了意想不到的高且难以解释的再生能力。
J Clin Med. 2025 Apr 8;14(8):2556. doi: 10.3390/jcm14082556.
4
Thrombolysis exacerbates cerebrovascular injury after ischemic stroke via a VEGF-B dependent effect on adipose lipolysis.溶栓通过血管内皮生长因子-B(VEGF-B)对脂肪分解的依赖性作用加重缺血性中风后的脑血管损伤。
bioRxiv. 2024 Oct 12:2024.10.11.617532. doi: 10.1101/2024.10.11.617532.
5
Interleukin-6 as a Director of Immunological Events and Tissue Regenerative Capacity in Hemodialyzed Diabetes Patients.白细胞介素-6 作为血液透析糖尿病患者免疫事件和组织再生能力的调控者。
Med Sci (Basel). 2024 Jun 15;12(2):31. doi: 10.3390/medsci12020031.
6
Comparison of Steroidogenic and Ovulation-Inducing Effects of Orthosteric and Allosteric Agonists of Luteinizing Hormone/Chorionic Gonadotropin Receptor in Immature Female Rats.促黄体生成素/绒毛膜促性腺激素受体正位和变构激动剂对未成年雌性大鼠的甾体生成和排卵诱导作用比较。
Int J Mol Sci. 2023 Nov 22;24(23):16618. doi: 10.3390/ijms242316618.
7
Effect of Operating Parameters on the Performance of Integrated Fixed-Film Activated Sludge for Wastewater Treatment.运行参数对一体化固定膜活性污泥法污水处理性能的影响
Membranes (Basel). 2023 Jul 28;13(8):704. doi: 10.3390/membranes13080704.
8
VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway.VEGF-B 通过抑制 FGF2/FGFR1 通路来防止过度血管生成。
Signal Transduct Target Ther. 2023 Aug 18;8(1):305. doi: 10.1038/s41392-023-01539-9.
9
Therapeutic Potential of VEGF-B in Coronary Heart Disease and Heart Failure: Dream or Vision?VEGF-B 在冠心病和心力衰竭中的治疗潜力:梦想还是愿景?
Cells. 2022 Dec 19;11(24):4134. doi: 10.3390/cells11244134.
10
Serum vascular endothelial growth factor b and metabolic syndrome incidence in the population based cohort Di@bet.es study.基于人群的 Di@bet.es 研究中血清血管内皮生长因子 b 与代谢综合征发生率的关系。
Int J Obes (Lond). 2022 Nov;46(11):2013-2020. doi: 10.1038/s41366-022-01212-1. Epub 2022 Aug 20.

本文引用的文献

1
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4).血管内皮生长因子D(VEGF-D)是酪氨酸激酶血管内皮生长因子受体2(Flk1)和血管内皮生长因子受体3(Flt4)的配体。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):548-53. doi: 10.1073/pnas.95.2.548.
2
Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.血管内皮生长因子(VEGF)与Flt-1受体结构域2复合物的1.7埃分辨率晶体结构。
Cell. 1997 Nov 28;91(5):695-704. doi: 10.1016/s0092-8674(00)80456-0.
3
Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.纤溶酶原激活剂、整合素以及细胞黏附与迁移的协同调节
Curr Opin Cell Biol. 1997 Oct;9(5):714-24. doi: 10.1016/s0955-0674(97)80126-3.
4
Proteolytic processing regulates receptor specificity and activity of VEGF-C.蛋白水解加工调节VEGF-C的受体特异性和活性。
EMBO J. 1997 Jul 1;16(13):3898-911. doi: 10.1093/emboj/16.13.3898.
5
Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.血管内皮生长因子:激酶结构域受体结合位点的晶体结构与功能图谱
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7192-7. doi: 10.1073/pnas.94.14.7192.
6
Molecular cloning of a novel vascular endothelial growth factor, VEGF-D.一种新型血管内皮生长因子VEGF-D的分子克隆
Genomics. 1997 Jun 15;42(3):483-8. doi: 10.1006/geno.1997.4774.
7
A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis.原始造血、定向造血及血管生成过程中对Flk1的需求。
Cell. 1997 Jun 13;89(6):981-90. doi: 10.1016/s0092-8674(00)80283-4.
8
The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.KDR/Flk-1(血管内皮生长因子受体-2)的230 kDa成熟形式激活PLC-γ途径,并在NIH3T3成纤维细胞中部分诱导有丝分裂信号。
Oncogene. 1997 May 1;14(17):2079-89. doi: 10.1038/sj.onc.1201047.
9
Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect.血管内皮生长因子189个氨基酸形式的细胞外裂解对于其促有丝分裂作用而言是必需的,此裂解由尿激酶介导。
J Biol Chem. 1997 May 16;272(20):13390-6. doi: 10.1074/jbc.272.20.13390.
10
Mechanisms of angiogenesis.血管生成的机制。
Nature. 1997 Apr 17;386(6626):671-4. doi: 10.1038/386671a0.

血管内皮生长因子B(VEGF-B)与血管内皮生长因子受体-1结合,并调节内皮细胞中的纤溶酶原激活物活性。

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells.

作者信息

Olofsson B, Korpelainen E, Pepper M S, Mandriota S J, Aase K, Kumar V, Gunji Y, Jeltsch M M, Shibuya M, Alitalo K, Eriksson U

机构信息

Ludwig Institute for Cancer Research, Stockholm Branch, Box 240, S-171 77 Stockholm, Sweden.

出版信息

Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11709-14. doi: 10.1073/pnas.95.20.11709.

DOI:10.1073/pnas.95.20.11709
PMID:9751730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC21705/
Abstract

The vascular endothelial growth factor (VEGF) family has recently expanded by the identification and cloning of three additional members, namely VEGF-B, VEGF-C, and VEGF-D. In this study we demonstrate that VEGF-B binds selectively to VEGF receptor-1/Flt-1. This binding can be blocked by excess VEGF, indicating that the interaction sites on the receptor are at least partially overlapping. Mutating the putative VEGF receptor-1/Flt-1 binding determinants Asp63, Asp64, and Glu67 to alanine residues in VEGF-B reduced the affinity to VEGF receptor-1 but did not abolish binding. Mutational analysis of conserved cysteines contributing to VEGF-B dimer formation suggest a structural conservation with VEGF and platelet-derived growth factor. Proteolytic processing of the 60-kDa VEGF-B186 dimer results in a 34-kDa dimer containing the receptor-binding epitopes. The binding of VEGF-B to its receptor on endothelial cells leads to increased expression and activity of urokinase type plasminogen activator and plasminogen activator inhibitor 1, suggesting a role for VEGF-B in the regulation of extracellular matrix degradation, cell adhesion, and migration.

摘要

血管内皮生长因子(VEGF)家族最近因另外三个成员即VEGF - B、VEGF - C和VEGF - D的鉴定与克隆而得到扩展。在本研究中,我们证明VEGF - B选择性地与VEGF受体 - 1/Flt - 1结合。这种结合可被过量的VEGF阻断,这表明受体上的相互作用位点至少部分重叠。将VEGF - B中假定的VEGF受体 - 1/Flt - 1结合决定簇天冬氨酸63、天冬氨酸64和谷氨酸67突变为丙氨酸残基会降低其对VEGF受体 - 1的亲和力,但不会消除结合。对促成VEGF - B二聚体形成的保守半胱氨酸进行的突变分析表明其与VEGF和血小板衍生生长因子在结构上具有保守性。60 kDa的VEGF - B186二聚体的蛋白水解加工产生一个含有受体结合表位的34 kDa二聚体。VEGF - B与其在内皮细胞上的受体结合会导致尿激酶型纤溶酶原激活剂和纤溶酶原激活剂抑制剂1的表达和活性增加,这表明VEGF - B在细胞外基质降解、细胞黏附和迁移的调节中发挥作用。